Velarion Records
Free. Unsubscribe any time.

Royalty Pharma plc (RPRX)

Royalty Pharma plc filed 35 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 70 transactions and 1,937,588 shares. None carries the SEC's AFF10B5ONE flag; all 35 name a plan in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Royalty Pharma plc 70

Adoption dates in Royalty Pharma plc 7

Results prints in Royalty Pharma plc 0

Trades before a print in Royalty Pharma plc 0

Interval to Royalty Pharma plc’s next reported results date

How the interval and sources are counted →

Adoption dates Royalty Pharma plc states

Filing text: “10b5-1 plan adopted by the Reporting Person on March 20, 2026”

Sources: SEC EDGAR full-text search and the SEC submissions API.

The address of this record

Royalty Pharma plc’s insider trading plan record — 35 Form 4 statements in the 2025 filing year — is published at one address, this page. When you cite or link the record, use https://velarionrecords.com/plan10b5/issuer/0001802768.